TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 118 filers reported holding TRICIDA INC in Q3 2020. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $68,505 | -99.7% | 455,300 | -79.6% | 0.00% | -100.0% |
| Q3 2022 | $23,427,000 | +159.4% | 2,235,395 | +139.6% | 0.01% | +250.0% |
| Q2 2022 | $9,030,000 | +87.5% | 932,863 | +59.2% | 0.00% | – |
| Q1 2022 | $4,817,000 | -41.6% | 585,973 | -32.1% | 0.00% | – |
| Q4 2021 | $8,250,000 | +967.3% | 862,934 | +417.9% | 0.00% | – |
| Q3 2021 | $773,000 | +47.5% | 166,625 | +37.3% | 0.00% | – |
| Q2 2021 | $524,000 | -48.9% | 121,348 | -37.4% | 0.00% | – |
| Q1 2021 | $1,026,000 | -35.7% | 193,953 | -14.2% | 0.00% | – |
| Q4 2020 | $1,596,000 | +90.5% | 226,144 | +144.4% | 0.00% | – |
| Q3 2020 | $838,000 | +312.8% | 92,515 | +1153.1% | 0.00% | – |
| Q2 2020 | $203,000 | +1.5% | 7,383 | -18.7% | 0.00% | – |
| Q1 2020 | $200,000 | -38.7% | 9,082 | -14.0% | 0.00% | – |
| Q3 2019 | $326,000 | -53.0% | 10,558 | -40.0% | 0.00% | – |
| Q2 2019 | $694,000 | +85.1% | 17,592 | +40.4% | 0.00% | – |
| Q2 2018 | $375,000 | – | 12,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 188,182 | $1,705,000 | 1.35% |
| Orbimed Advisors | 9,614,280 | $87,105,000 | 1.10% |
| Redmile Group, LLC | 2,858,415 | $25,897,000 | 0.48% |
| Cormorant Asset Management, LP | 727,975 | $6,595,000 | 0.25% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 65,419 | $593,000 | 0.17% |
| Vivo Capital, LLC | 174,763 | $1,583,000 | 0.09% |
| Palo Alto Investors LP | 170,800 | $1,547,000 | 0.08% |
| Berman Capital Advisors, LLC | 30,950 | $280,000 | 0.08% |
| DUALITY ADVISERS, LP | 130,320 | $1,181,000 | 0.08% |
| PDT Partners, LLC | 125,026 | $1,133,000 | 0.08% |